Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Pathologic differential diagnosis of metastatic carcinoma in the liver

Jeong Hwan Park, Jung Ho Kim

Clin Mol Hepatol. 2019;25(1):12-20. Published online October 5, 2018

DOI: https://doi.org/10.3350/cmh.2018.0067

View: 28154 Download: 1,145 Web of Science: 44 Crossref: 48

Recent research trends and updates on nonalcoholic fatty liver disease

Jeong-Ju Yoo, Won Kim, Moon Young Kim, Dae Won Jun, Sang Gyune Kim, Jong-Eun Yeon, Jin Woo Lee, Yong Kyun Cho, Sang Hoon Park, Joo Hyun Sohn, On behalf of the Korean Association for the Study of the Liver (KASL)-Korea Nonalcoholic fatty liver Study Group (KNSG)

Clin Mol Hepatol. 2019;25(1):1-11. Published online August 8, 2018

DOI: https://doi.org/10.3350/cmh.2018.0037

View: 20139 Download: 728 Web of Science: 70 Crossref: 67

Severe acute alcoholic hepatitis and liver transplant: A never-ending mournful story

Aiman Obed, Abdalla Bashir, Steffen Stern, Anwar Jarrad

Clin Mol Hepatol. 2018;24(4):358-366. Published online October 24, 2018

DOI: https://doi.org/10.3350/cmh.2018.0044

View: 10793 Download: 207 Web of Science: 4 Crossref: 6

Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals

Soon Young Ko, Won Hyeok Choe

Clin Mol Hepatol. 2018;24(4):351-357. Published online March 16, 2018

DOI: https://doi.org/10.3350/cmh.2017.0063

View: 10741 Download: 352 Web of Science: 4 Crossref: 1

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL

Jong Eun Yeon

Clin Mol Hepatol. 2018;24(3):278-293. Published online May 2, 2018

DOI: https://doi.org/10.3350/cmh.2018.1002

View: 11418 Download: 243 Web of Science: 15 Crossref: 14

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2018;24(3):230-277. Published online July 9, 2018

DOI: https://doi.org/10.3350/cmh.2018.1005

View: 32207 Download: 801 Web of Science: 45 Crossref: 48

2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2018;24(3):169-229. Published online August 10, 2018

DOI: https://doi.org/10.3350/cmh.2018.1004

View: 15999 Download: 230 Web of Science: 21 Crossref: 28

Strategic application of radiotherapy for hepatocellular carcinoma

Seo Hee Choi, Jinsil Seong

Clin Mol Hepatol. 2018;24(2):114-134. Published online February 14, 2018

DOI: https://doi.org/10.3350/cmh.2017.0073

View: 15596 Download: 399 Web of Science: 41 Crossref: 46

Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend

Grace Lai-Hung Wong

Clin Mol Hepatol. 2018;24(2):108-113. Published online January 22, 2018

DOI: https://doi.org/10.3350/cmh.2017.0068

View: 14691 Download: 519 Web of Science: 40 Crossref: 40

Microbiota, a key player in alcoholic liver disease

Anne-Marie Cassard, Dragos Ciocan

Clin Mol Hepatol. 2018;24(2):100-107. Published online December 22, 2017

DOI: https://doi.org/10.3350/cmh.2017.0067

View: 13405 Download: 546 Web of Science: 73 Crossref: 73

Epidemiology of alcoholic liver disease in Korea

Jae Young Jang, Dong Joon Kim

Clin Mol Hepatol. 2018;24(2):93-99. Published online March 16, 2018

DOI: https://doi.org/10.3350/cmh.2017.0079

View: 13860 Download: 275 Web of Science: 24 Crossref: 22

Role of liver transplantation in severe alcoholic hepatitis

Ravi Daswani, Ashish Kumar, Praveen Sharma, Vikas Singla, Naresh Bansal, Anil Arora

Clin Mol Hepatol. 2018;24(1):43-50. Published online January 10, 2018

DOI: https://doi.org/10.3350/cmh.2017.0027

View: 10426 Download: 184 Web of Science: 8 Crossref: 10

Prevention and management of gastroesophageal varices

Yeon Seok Seo

Clin Mol Hepatol. 2018;24(1):20-42. Published online December 18, 2017

DOI: https://doi.org/10.3350/cmh.2017.0064

View: 23762 Download: 809 Web of Science: 66 Crossref: 77

Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea

Sook-Hyang Jeong

Clin Mol Hepatol. 2018;24(1):10-19. Published online January 5, 2018

DOI: https://doi.org/10.3350/cmh.2017.0066

View: 12213 Download: 297 Web of Science: 19 Crossref: 18

Epidemiology of liver cancer in South Korea

Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2018;24(1):1-9. Published online December 18, 2017

DOI: https://doi.org/10.3350/cmh.2017.0112

View: 16808 Download: 503 Web of Science: 146 Crossref: 152

Histopathological evaluation of liver fibrosis and cirrhosis regression

Regina C. Lo, Haeryoung Kim

Clin Mol Hepatol. 2017;23(4):302-307. Published online December 20, 2017

DOI: https://doi.org/10.3350/cmh.2017.0078

View: 17674 Download: 560 Web of Science: 97 Crossref: 96

Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification

Dong Ho Lee

Clin Mol Hepatol. 2017;23(4):290-301. Published online October 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0042

View: 23743 Download: 502 Web of Science: 109 Crossref: 104

Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system

Tae Kyoung Kim, Seung Yeon Noh, Stephanie R Wilson, Yuko Kono, Fabio Piscaglia, Hyun-Jung Jang, Andrej Lyshchik, Christoph F. Dietrich, Juergen K. Willmann, Alexander Vezeridis, Claude B Sirlin

Clin Mol Hepatol. 2017;23(4):280-289. Published online September 15, 2017

DOI: https://doi.org/10.3350/cmh.2017.0037

View: 17124 Download: 423 Web of Science: 99 Crossref: 102

Treatment options after sorafenib failure in patients with hepatocellular carcinoma

Imane El Dika, Ghassan K. Abou-Alfa

Clin Mol Hepatol. 2017;23(4):273-279. Published online November 20, 2017

DOI: https://doi.org/10.3350/cmh.2017.0108

View: 10184 Download: 239 Web of Science: 30 Crossref: 30

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma

Edward Wolfgang Lee, Sarah Khan

Clin Mol Hepatol. 2017;23(4):265-272. Published online November 8, 2017

DOI: https://doi.org/10.3350/cmh.2017.0111

View: 12488 Download: 365 Web of Science: 38 Crossref: 38

Current status of and strategies for hepatitis C control in South Korea

Beom Kyung Kim, Eun Sun Jang, Jeong Han Kim, Soo Young Park, Song Vogue Ahn, Hyung Joon Kim, Do Young Kim

Clin Mol Hepatol. 2017;23(3):212-218. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0105

View: 8994 Download: 240 Web of Science: 18 Crossref: 20

Current status and strategies for hepatitis B control in Korea

Eun Ju Cho, Sung Eun Kim, Ki Tae Suk, Jihyun An, Soung Won Jeong, Woo Jin Chung, Yoon Jun Kim

Clin Mol Hepatol. 2017;23(3):205-211. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0104

View: 14138 Download: 319 Web of Science: 87 Crossref: 87

Current status and strategies for the control of viral hepatitis A in Korea

Eileen L. Yoon, Dong Hyun Sinn, Hyun Woong Lee, Ji Hoon Kim

Clin Mol Hepatol. 2017;23(3):196-204. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0034

View: 10115 Download: 210 Web of Science: 19 Crossref: 20

Current status and strategies for viral hepatitis control in Korea

Dong Hyun Sinn, Eun Ju Cho, Ji Hoon Kim, Do Young Kim, Yoon Jun Kim, Moon Seok Choi

Clin Mol Hepatol. 2017;23(3):189-195. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0033

View: 9821 Download: 248 Web of Science: 21 Crossref: 22

Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues

Dong Joon Kim, Moon Seok Choi

Clin Mol Hepatol. 2017;23(2):115-122. Published online May 2, 2017

DOI: https://doi.org/10.3350/cmh.2017.0018

View: 10343 Download: 236 Web of Science: 14 Crossref: 16

Radioembolization for the treatment of hepatocellular carcinoma

Hyo-Cheol Kim

Clin Mol Hepatol. 2017;23(2):109-114. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0004

View: 13539 Download: 372 Web of Science: 50 Crossref: 44

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs

Stephen Caldwell

Clin Mol Hepatol. 2017;23(2):103-108. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0103

View: 13618 Download: 485 Web of Science: 35 Crossref: 34

The use of immunosuppression in autoimmune hepatitis: A current literature review

Angela Cropley, Martin Weltman

Clin Mol Hepatol. 2017;23(1):22-26. Published online March 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0089

View: 30746 Download: 430 Web of Science: 16 Crossref: 19

Anticoagulation in cirrhosis: a new paradigm?

Filippo Leonardi, Nicola De Maria, Erica Villa

Clin Mol Hepatol. 2017;23(1):13-21. Published online March 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0110

View: 16179 Download: 821 Web of Science: 48 Crossref: 53

Genetic predisposition in nonalcoholic fatty liver disease

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol. 2017;23(1):1-12. Published online March 9, 2017

DOI: https://doi.org/10.3350/cmh.2016.0109

View: 19493 Download: 618 Web of Science: 160 Crossref: 160

Viewed By 7365	MAFLD: How is it different from NAFLD?
Viewed By 6926	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5571	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5341	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4767	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 270	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 186	MAFLD: How is it different from NAFLD?
Cited By 93	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Review